An international team of medical researchers associated with the nonprofit Alzheimer’s Association has published a paper describing the group’s final version of their new diagnostic criteria for the disease. Published in Nature Medicine, the paper includes use of plasma biomarkers in diagnosing symptomatic Alzheimer’s patients. For many years, the decision to diagnose a patient with Alzheimer’s disease during its early stages has been based mostly on symptoms rather than physical tests. In more recent years, researchers have found protein-based biomarkers that can be used to diagnose patients more accurately. In Read More